Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2026-02-28 @ 7:09 PM
Study NCT ID:
NCT06350318
Status:
RECRUITING
Last Update Posted:
2025-11-03
First Post:
2024-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2029-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-01
First Submit QC Date:
None
Study First Post Date:
2024-04-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-30
Last Update Post Date:
2025-11-03
Last Update Post Date Type:
ESTIMATED